PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Digital manufacturing is a top priority for Life Sciences according to Zenith survey

Zenith Technologies, a world leader in delivering GMP manufacturing software solutions to the life sciences industry, recently conducted an industry survey that sugg...
Continue Reading →
News

Digital revolution in ophthalmology: Artificial Intelligence and Big Data make for even better diagnosis and treatment

(Vienna, 21 November 2018) "Exactly one year ago, we spoke about the fact that, in future, it will be possible to diagnose diabetes from the eye using automatic digi...
Continue Reading →
News

Access to medicine after Brexit: Lords ask Minister for clarity

The House of Lords EU Home Affairs Sub-Committee has today written to Matt Hancock MP, Secretary of State for Health and Social Care (DHSC) asking for clarity on the...
Continue Reading →
News

Global chronic lymphocytic leukemia market set to reach $9.2bn by 2027, says GlobalData

The chronic lymphocytic leukemia (CLL) market is expected to grow from $7.7bn in 2017 to $9.2bn by 2027 across the seven major markets (7MM*) at a compound annual gr...
Continue Reading →
News

UK and EU’s future relationship ‘must protect patients’

UK coalition concerned about regulation, data sharing, infectious disease controls. After the draft Brexit withdrawal agreement, Theresa May’s hard-fough...
Continue Reading →
News

Scorpion venom to shuttle drugs into the brain

The Peptides and Proteins lab at the Institute for Research in Biomedicine (IRB Barcelona) has published a paper in Chemical Communications describing the capacity o...
Continue Reading →
News

Aspirin and omega-3 reduce pre-cancerous bowel polyps

Both aspirin and a purified omega-3, called EPA, reduce the number of pre-cancerous polyps in patients found to be at high risk of developing bowel cancer, according...
Continue Reading →
News

European Commission approves Lilly's Emgality for migraine

Eli Lilly has confirmed that Emgality, a once-monthly monoclonal antibody injection, has been approved by the European Commission for preventive treatment of mi...
Continue Reading →
News

Sandoz abandoning US development of Rixathon to focus on more lucrative markets will benefit the company in the long term, says GlobalData

Novartis’ Sandoz division recently announced that it was no longer pursuing US approval for Rixathon, its biosimilar version of Roche’s Rituxan/MabThera (rituximab)....
Continue Reading →
News

The Access to Medicine Index finds that a handful of pharmaceutical companies are developing the bulk of urgently needed new medicines for the poor

Amsterdam the Netherlands, 20 November 2018 – The development of new medical products that are considered the highest priority for people in developing countries is ...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026